Sunday, Nov 22, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Hyderabad | Nucelion Therapeutics And Pandorum Technologies Partner On Ophthalmology Projects

Nucelion Therapeutics and Pandorum Technologies partner on ophthalmology projects

Hyderabad-based Nucelion Therapeutics and Bengaluru's Pandorum Technologies have partnered to advance two PRIP-backed ophthalmology projects targeting advanced keratopathy and wet age-related macular degeneration. The projects have a combined planned outlay of Rs. 16.97 crore, including up to Rs. 8 crore in PRIP funding

By Telangana Today
Published Date - 28 October 2026, 04:39 PM
Nucelion Therapeutics and Pandorum Technologies partner on ophthalmology projects
whatsapp facebook twitter telegram

Hyderabad: Hyderabad-based Nucelion Therapeutics, a subsidiary of Bharat Biotech, and Bengaluru’s Pandorum Technologies have announced a manufacturing partnership to advance two Promotion of Research and Innovation in Pharma-MedTech (PRIP)-backed ophthalmology projects targeting advanced keratopathy and wet age-related macular degeneration (wet AMD), a press release said.

The collaboration combines Pandorum’s designer-exosome platform, focusing on cell-free regenerative medicines that address inflammation, fibrosis, and vascular pathology, with Nucelion’s expertise in Good Manufacturing Practice (GMP) process development and manufacturing.


The initiative aims to support clinical studies both in India and internationally. The projects feature a combined planned outlay of Rs 16.97 crore, which includes up to Rs 8 crore in funding under the PRIP scheme.

Dr. Raghu Malapaka, Chief Business Officer for Nucelion said that it is important to translate product requirements into reproducible processes with built-in quality.

Dr. Tuhin Bhowmick, Co-founder and CEO of Pandorum, said that the partnership connects their designer-exosome platform to rigorous manufacturing capabilities under the ‘Innovate and Make in India, for the World’ vision.

Join Our Whatsapp Channel
  • Follow Us :
As preferred source
  • Tags
  • Bharat Biotech subsidiary
  • Nucelion Therapeutics
  • Pandorum Technologies

Related News

  • Bharat Biotech arm Nucelion partners with VeGen Bio on CAR-T therapy

    Bharat Biotech arm Nucelion partners with VeGen Bio on CAR-T therapy

  • Pandorum teams up with Bharat Biotech subsidiary

    Pandorum teams up with Bharat Biotech subsidiary

Latest News

  • BRS flags Hyderabad drinking water concerns, seeks KRMB intervention

    18 minutes ago
  • Bahrain says two hurt in Iranian strikes, condemns sovereignty violations

    14 minutes ago
  • Karimnagar GMC medicos protest lack of hostels, lecture halls

    43 minutes ago
  • KTR extends support to protesting medical students in Karimnagar

    1 hour ago
  • Redkarpet Jewel Exhibitions unveils curtain-raiser for Hyderabad jewellery expo

    1 hour ago
  • Countdown has begun for Congress, KCR’s return inevitable: KTR

    2 hours ago
  • TGTDC organises heritage-nature walk at Qutb Shahi Tombs

    2 hours ago
  • Chevella woman murdered after theft complaint; suspect held in 24 hours

    2 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App